|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.997
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.992
|
Mouse |
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.991
|
|
|
|
detection of light stimulus
|
GO:0009583 |
25 |
0.982
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.972
|
|
|
|
retinal cone cell development
|
GO:0046549 |
8 |
0.968
|
|
|
|
phototransduction
|
GO:0007602 |
17 |
0.920
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.879
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.865
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.861
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.831
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.775
|
|
|
|
detection of visible light
|
GO:0009584 |
14 |
0.711
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.665
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.652
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.646
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.612
|
|
|
|
lipoprotein transport
|
GO:0042953 |
7 |
0.606
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.584
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.568
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.566
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.561
|
Mouse |
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.534
|
|
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
13 |
0.508
|
|
|
|
phototransduction visible light
|
GO:0007603 |
6 |
0.505
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.495
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.467
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.467
|
Mouse |
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
21 |
0.431
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.430
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.399
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.393
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.388
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.378
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.374
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.367
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.363
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.359
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.354
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.348
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.346
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.342
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.342
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.341
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.337
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.333
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.328
|
|
|
|
maintenance of epithelial cell apical basal polarity
|
GO:0045199 |
2 |
0.326
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.322
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
52 |
0.317
|
Mouse |
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.310
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.304
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.292
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.292
|
|
|
|
negative regulation of oxidative phosphorylation uncoupler activity
|
GO:2000276 |
2 |
0.286
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.284
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.284
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.283
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.283
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.279
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.277
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.277
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.265
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.260
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.258
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.252
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.250
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.246
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.244
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.243
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.242
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.242
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.240
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.237
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.237
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.236
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.236
|
|
|
|
notochord formation
|
GO:0014028 |
5 |
0.236
|
|
|
|
positive regulation of exit from mitosis
|
GO:0031536 |
1 |
0.229
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.228
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.226
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.226
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.226
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.225
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.219
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.218
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.217
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
23 |
0.215
|
|
|
|
regulation of intestinal epithelial structure maintenance
|
GO:0060730 |
1 |
0.211
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.208
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.206
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.204
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.203
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.201
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.201
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.199
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.198
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.198
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.197
|
|
|
|
establishment or maintenance of epithelial cell apical basal polarity
|
GO:0045197 |
14 |
0.197
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.196
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.195
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.194
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.193
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.193
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.192
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.192
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.191
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.188
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.186
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.185
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.185
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.184
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.184
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.179
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.175
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.175
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.173
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.173
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.169
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.169
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.167
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.165
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.165
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.165
|
|
|
|
cgmp catabolic process
|
GO:0046069 |
2 |
0.162
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.161
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.161
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.159
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.158
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.158
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.157
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.156
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.154
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.153
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.152
|
Mouse |
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.149
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.148
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.148
|
|
|
|
negative regulation of type b pancreatic cell apoptotic process
|
GO:2000675 |
3 |
0.147
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.146
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.146
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.146
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.145
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.141
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.138
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.137
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.136
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.136
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.133
|
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.131
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.131
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.129
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.129
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.128
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.128
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.128
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.127
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.126
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.126
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.126
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.125
|
|
|
|
regulation of rhodopsin gene expression
|
GO:0007468 |
3 |
0.124
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.123
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.122
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.118
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.118
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.117
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.116
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.115
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.113
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.112
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.112
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.111
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.110
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.107
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.107
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.107
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.106
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.106
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.106
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.105
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.104
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.103
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.103
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.101
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.101
|
|
|
|
sympathetic nervous system development
|
GO:0048485 |
22 |
0.101
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.101
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.100
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.100
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.098
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.098
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.097
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.097
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.096
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.096
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.095
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.095
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.095
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.094
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.094
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.093
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.092
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.092
|
|
|
|
rhombomere development
|
GO:0021546 |
8 |
0.092
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.090
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.090
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.090
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.090
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.090
|
|
|
|
gonad morphogenesis
|
GO:0035262 |
1 |
0.089
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.089
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.089
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.088
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.088
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.087
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.087
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.086
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.086
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.086
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.085
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.085
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.085
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.084
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.084
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.084
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.084
|
|
|
|
positive regulation of rhodopsin gene expression
|
GO:0045872 |
2 |
0.083
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.082
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.082
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.082
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.081
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.080
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.079
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.079
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.079
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.076
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.075
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.075
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.075
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.074
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.074
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.073
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.073
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.073
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.073
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.072
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.071
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.071
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.071
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.070
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.070
|
|
|
|
striated muscle cell apoptotic process
|
GO:0010658 |
12 |
0.070
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.069
|
|
|
|
multi organism reproductive behavior
|
GO:0044705 |
29 |
0.068
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.068
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.067
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
32 |
0.067
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.067
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.067
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.066
|
|
|
|
vitamin a metabolic process
|
GO:0006776 |
2 |
0.066
|
|
|
|
sensory perception of smell
|
GO:0007608 |
26 |
0.066
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.066
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.065
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.064
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.064
|
|
|
|
retinal cone cell differentiation
|
GO:0042670 |
8 |
0.064
|
|
|
|
behavioral defense response
|
GO:0002209 |
28 |
0.064
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.064
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.064
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.063
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.063
|
|
|
|
regulation of retina development in camera type eye
|
GO:1902866 |
3 |
0.063
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.063
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.062
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.062
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.062
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.062
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.061
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.061
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.061
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.061
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.060
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.060
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.060
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.060
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.060
|
|
|
|
cgmp metabolic process
|
GO:0046068 |
20 |
0.059
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.059
|
|
|
|
photoreceptor cell maintenance
|
GO:0045494 |
19 |
0.059
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.058
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.058
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.058
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.058
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.058
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.057
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.057
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.057
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.057
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.056
|
|
|
|
behavioral fear response
|
GO:0001662 |
28 |
0.056
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.056
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.056
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.056
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.056
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.056
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.056
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.055
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.055
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.055
|
|
|
|
camera type eye photoreceptor cell differentiation
|
GO:0060219 |
15 |
0.054
|
Mouse |
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.054
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.054
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.054
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.054
|
|
|
|
negative regulation of tumor necrosis factor production
|
GO:0032720 |
17 |
0.054
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.054
|
|
|
|
regulation of type b pancreatic cell apoptotic process
|
GO:2000674 |
5 |
0.053
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.053
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
32 |
0.053
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.053
|
|
|
|
establishment of monopolar cell polarity
|
GO:0061162 |
8 |
0.053
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.052
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.052
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.052
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.052
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.051
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.051
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
18 |
0.050
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.050
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.050
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.050
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.049
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.049
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.049
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.049
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.049
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.048
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.048
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.048
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.047
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
13 |
0.047
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.047
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.047
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.047
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.046
|
|
|
|
amacrine cell differentiation
|
GO:0035881 |
5 |
0.046
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.046
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.046
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.046
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.045
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.045
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.045
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.045
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.045
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.045
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.044
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.044
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.044
|
|
|
|
rhombomere 5 development
|
GO:0021571 |
4 |
0.044
|
|
|
|
heart formation
|
GO:0060914 |
16 |
0.044
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.043
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.043
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.043
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.043
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.043
|
|
|
|
hydrogen transport
|
GO:0006818 |
35 |
0.042
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.042
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.042
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.042
|
|
|
|
hypothalamus cell differentiation
|
GO:0021979 |
8 |
0.042
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.042
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.042
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.041
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.041
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.041
|
|
|
|
neuron recognition
|
GO:0008038 |
25 |
0.041
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.041
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.041
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.041
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.041
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.041
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.041
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.041
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.040
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.040
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.040
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.040
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.039
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.039
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.039
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.039
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.039
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.039
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.039
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.039
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.039
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.039
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.038
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.038
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.038
|
|
|
|
respiratory system process
|
GO:0003016 |
25 |
0.038
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.038
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.038
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.038
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.037
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.037
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.037
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.037
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.037
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
8 |
0.036
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.036
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.036
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.036
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.036
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.036
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.036
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.036
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.036
|
|
|
|
mitochondrion localization
|
GO:0051646 |
9 |
0.036
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.036
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.036
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.036
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.036
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.036
|
|
|
|
neuromuscular process controlling posture
|
GO:0050884 |
14 |
0.036
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.035
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.035
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.035
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.035
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.035
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.035
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.035
|
|
|
|
regulation of multicellular organismal metabolic process
|
GO:0044246 |
14 |
0.035
|
|
|
|
retina layer formation
|
GO:0010842 |
16 |
0.035
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.035
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.034
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.034
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.034
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.034
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.034
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.034
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.034
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.034
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.034
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.034
|
|
|
|
negative regulation of camp metabolic process
|
GO:0030815 |
5 |
0.034
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.034
|
|
|
|
notochord morphogenesis
|
GO:0048570 |
10 |
0.034
|
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.034
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.034
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.034
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.033
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.033
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.033
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.033
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.033
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.033
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.033
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.033
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.033
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.033
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.033
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.032
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.032
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.032
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.032
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.032
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.032
|
|
|
|
regulation of mechanoreceptor differentiation
|
GO:0045631 |
5 |
0.032
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.032
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.032
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.032
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.032
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.032
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.032
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.032
|
|
|
|
catecholamine biosynthetic process
|
GO:0042423 |
11 |
0.032
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.031
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.031
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.031
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.031
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.031
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.031
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.031
|
|
